Delaware § 4902 Sale or distribution of laetrile; labeling requirement

Delaware Statutes

§ 4902 — Sale or distribution of laetrile; labeling requirement

Delaware § 4902

Title16

PartFood and Drugs

Ch. 49NATURAL FOOD SUBSTANCES

This text of Delaware § 4902 (Sale or distribution of laetrile; labeling requirement) is published on Counsel Stack Legal Research, covering Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Del. Code tit. 16, § 4902 (2026).

Text

Laetrile (amygdalin, Vitamin B-17) may be distributed or sold by any person, and no special license or prescription shall be required for the sale or distribution of such substance. The label or other device affixed to a container containing laetrile (amygdalin, Vitamin B-17) shall include a statement that such substance has not yet been approved as a treatment or cure for cancer by the Food and Drug Administration of the United States Department of Health, Education and Welfare.

Free access — add to your briefcase to read the full text and ask questions with AI

Laetrile (amygdalin, Vitamin B-17) may be distributed or sold by any person, and no special license or prescription shall be required for the sale or distribution of such substance. The label or other device affixed to a container containing laetrile (amygdalin, Vitamin B-17) shall include a statement that such substance has not yet been approved as a treatment or cure for cancer by the Food and Drug Administration of the United States Department of Health, Education and Welfare.